Join the 'Colchicine' group to help and get support from people like you.
Newly-Published Colchicine Safety Data Provide First Evidence-Based Dosing Guidance to Avoid Potentially Serious Interactions With Commonly Prescribed Drugs
Posted 11 Aug 2011 by Drugs.com
- Paper Published in August Issue of Arthritis & Rheumatism Highlights Several Previously Unknown Drug-Drug Interactions - Colchicine Dose Reductions Necessary in Presence of Certain CYP3A4 or P-gp Inhibitors - Studies Supported URL Pharma Clinical Research Program that Led to FDA Approval of Colcrys® PHILADELPHIA, Aug. 11, 2011 /PRNewswire/ – Newly-published results from a series of ...
Posted 1 Oct 2010 by Drugs.com
Drug commonly used to prevent gout, treat gout flares, and treat Familial Mediterranean Fever (FMF) ROCKVILLE, Md., Sept. 30, 2010--The U.S. Food and Drug Administration today took action against companies that manufacture, distribute, and/or market unapproved single-ingredient oral colchicine, a medication commonly used for the daily prevention of gout, to treat acute gout flare-ups, and for the ...
Posted 2 Dec 2009 by Drugs.com
New Colchicine Formulation Significantly Reduces Side Effects, Maintains Full Efficacy; Now Indicated for Both Prophylaxis and Treatment of Gout Flares PHILADELPHIA, Oct. 19 /PRNewswire/ – URL Pharma, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved Colcrys (colchicine, USP) for the prophylaxis (prevention) of gout flares. Colcrys was first approved by the FDA ...
FDA Medwatch Alert: Injectable Colchicine (including drugs containing colchicine)
Posted 6 Feb 2008 by Drugs.com
[Posted 02/06/2008] FDA announced its intention to take enforcement action against companies marketing unapproved, injectable colchicine, a drug used to treat gout. Colchicine is a highly toxic drug that can easily be administered in excessive doses, especially when given intravenously. There is a narrow margin between an effective dose of the drug and a toxic dose that can result in serious ...
FDA Medwatch Alert: Colchicine Compounded Injectable Products (Posted 05/02/2007)
Posted 2 May 2007 by Drugs.com
[Posted 05/02/2007] ApothéCure and FDA notified all healthcare professionals of recent deaths associated with the use of compounded injectable Colchicine 0.5mg/ml, 4ml vials, lot number 20070122@26. The company issued an immediate drug recall for all strengths, sizes and lots of compounded Injectable Colchicine sold within the last year. Customers are asked to examine their stock for ...
Related Condition Support Groups
Gout - Acute, Gout - Prophylaxis, Behcet's Disease, Amyloidosis, Aphthous Stomatitis - Recurrent, Familial Mediterranean Fever, Constipation - Chronic, Fibromatosis, Linear IgA Disease, Biliary Cirrhosis, Pseudogout - Prophylaxis, Sarcoidosis, Sweet's Syndrome